[Treatment of septicemia and severe infections with a cefradine-tobramycin combination].
The cefradine-tobramycine association was used in 11 cases of septicaemia and in 10 cases of non-septicaemic severe poly-infections. In 15 cases, the treatment was undertaken because of the serious state of the patients before the bacteriologic results were known. This association is characterized by its great effectiveness and its very good tolerance, mainly from the renal point of view. The results shown here corroborate those two elements.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002511:Cephalosporins / Q000627:therapeutic use*; D002515:Cephradine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D007668:Kidney / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D014031:Tobramycin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D002515:Cephradine; D014031:Tobramycin
Traitement des septicémies et des infections graves par l'association céfradine-tobramycine